ABMC Reports Fourth Quarter and Fiscal Year
End 2009 Results
March 24, 2010 04:03 PM Eastern Daylight Time
KINDERHOOK, N.Y.--(EON: Enhanced Online News)--American Bio Medica Corporation (Pink
Sheets: ABMC) today announced financial results for the fourth quarter and the year ended December 31, 2009.
Net sales for the fourth quarter of 2009 were $2,163,000 a decrease of $126,000, or 5.5% from $2,289,000
reported in the fourth quarter of 2008. Operating loss for the fourth quarter of 2009 was $114,000 compared to an
operating loss of $557,000 for the fourth quarter of 2008. Net loss for the fourth quarter of 2009 was $189,000, or
$0.01 per share, compared to a net loss of $672,000, or $0.03 per share, for the fourth quarter of 2008.
Net sales for the year ended December 31, 2009 were $9,726,000 compared to $12,657,000 for the year ended
December 31, 2008, representing a decrease in sales of $2,931,000 or 23.2%. Operating loss for 2009 was
$672,000, compared to an operating loss of $626,000 in 2008. The Company reported a net loss of $900,000, or
$0.04 per share, for 2009, compared to a net loss of $850,000, or $0.04 per share, for 2008.
ABMC Chief Executive Officer, Stan Cipkowski, stated, “Unprecedented unemployment and reduced government
budgets negatively impacted our business throughout 2009. We remain hopeful that employment will return to pre-
recession levels, but we realize this will take some time along with the time it will take before government budgets are
back to normal. To get through this difficult period, we have significantly reduced operating expenses and we will
continue to take every step necessary to minimize any losses going forward.”
The Company will host a conference call and webcast to discuss year-end and fourth quarter 2009 results on
Thursday, March 25, 2010 at 11:00 am (ET). Investors and interested parties are invited to participate. The call will
be broadcast live over the internet at www.abmc.com/investor/. The webcast will be listen-on